Sagimet Biosciences Inc. Series A Common Stock (SGMT) — Long-term Investment Intensity
Sagimet Biosciences Inc. Series A Common Stock (SGMT) has a Long-term Investment Intensity of 6.9% as of September 2025. Long-term investments of $8.81 Million represent 6.9% of total assets of $128.40 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See SGMT book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Sagimet Biosciences Inc. Series A Common Stock Long-term Investment Intensity (2024–2024)
This chart shows how Sagimet Biosciences Inc. Series A Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of September 2025, the intensity stands at 6.9%, reflecting long-term investments of $8.81 Million against total assets of $128.40 Million USD. Also explore Sagimet Biosciences Inc. Series A Common balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Sagimet Biosciences Inc. Series A Common Stock (2024–2024)
The table below presents the year-by-year Long-term Investment Intensity for Sagimet Biosciences Inc. Series A Common Stock from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Sagimet Biosciences Inc. Series A Common market cap and net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 4.6% | $7.41 Million | $160.26 Million | — |